Back to School: How biopharma can reboot drug development. Access exclusive analysis here

BASF to spend $674.7 million on agbio

BASF (Ludwigshafen, Germany) said it will allocate EUR700 million ($674.7 million)

Read the full 115 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE